Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
26%
OVERLAP
BY WEIGHT
18
# OF OVERLAPPING
HOLDINGS
FBT
31
HOLDINGS
60%
ALSO IN XBI
XBI
143
HOLDINGS
13%
ALSO IN FBT
SECTOR DRIFT (FBT minus XBI)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FBT |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 3.3% | 1.8% | 1.8% |
|
HALOZYME THERAPEUTICS INC | 3.8% | 1.8% | 1.8% |
|
BIOGEN IDEC INC | 3.6% | 1.7% | 1.7% |
|
AMGEN INC | 3.6% | 1.7% | 1.7% |
|
EXELIXIS INC | 3.7% | 1.7% | 1.7% |
FBT Overweight Relative to XBI
 |
GENMAB A/S SPONSORED ADR | 4.9% |
 |
ARGENX SE ADR | 3.4% |
|
NEOGENOMICS INC | 3.4% |
|
BEIGENE LTD. SPONSORED ADR | 3.3% |
|
TARSUS PHARMACEUTICALS, INC. | 3.3% |
|
REPLIGEN CORP | 3.2% |
|
BIO-TECHNE CORPORATION | 3.2% |
|
BRUKER CORP | 3.1% |
|
ADMA BIOLOGICS, INC. | 3.0% |
 |
BIONTECH SE SPONSORED ADR | 2.9% |
FBT Underweight Relative to XBI
|
MODERNA, INC. | -2.4% |
|
TWIST BIOSCIENCE CORP. | -1.8% |
|
ABBVIE INC | -1.7% |
|
SPYRE THERAPEUTICS INC | -1.6% |
|
ORUKA THERAPEUTICS INC | -1.5% |
|
PROTAGONIST THERAPEUTICS, INC. | -1.4% |
|
BRIDGEBIO PHARMA, INC. | -1.4% |
|
KRYSTAL BIOTECH, INC. | -1.4% |
|
GRAIL INC | -1.4% |
|
CRISPR THERAPEUTICS AG | -1.4% |